Verisian

About Verisian

Verisian is a pioneering startup in the healthcare and pharmaceutical industry, offering a groundbreaking platform designed to accelerate the time it takes to bring new drugs to market. The company serves pharmaceutical companies, biotech firms, and clinical research organizations (CROs) that are involved in the development and approval of new medications. Verisian operates in the clinical trials and drug development market, a critical sector that demands high levels of accuracy, transparency, and speed.

The core of Verisian's business model is its innovative platform, Verisian Tracer, which provides real study traceability and ensures the integrity of clinical trials. This platform allows clients to track every step of their clinical studies in real-time, ensuring complete transparency and faster development cycles. By parsing study code and leveraging advanced technology, Verisian enables clients to understand exactly what happened during a study, thereby enhancing confidence in the trial's results.

Verisian also offers Verisian Builder, a tool that accelerates the clinical trial study build process. This tool provides access to a rich library of pre-approved TFL (Tables, Figures, and Listings) ADaM (Analysis Data Model) derivation modules. These modules automate the derivation process from eCRF (electronic Case Report Forms), SDTM (Study Data Tabulation Model), and ADaM to TFL, making the study build process more efficient. Additionally, Verisian Builder allows for the extraction and virtualization of derivation paths from existing studies, facilitating effortless code reuse and further speeding up the study build process.

Verisian makes money by offering its platform and tools on a subscription basis or through licensing agreements with its clients. This model ensures a steady revenue stream while providing significant value to its clients by reducing the time and cost associated with drug development.

In summary, Verisian is revolutionizing the clinical trials process with its innovative technology, providing unparalleled study traceability and integrity, and significantly accelerating drug time to market.